Status:
RECRUITING
EMDR Treatment in PTSD Following Cardiac Events
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
EMDR Europe
Stiftung zur Förderung von Psychiatrie und Psychotherapie
Conditions:
Posttraumatic Stress Disorder
Myocardial Infarction
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Cardiac events can often result in debilitating and persistent psychological symptoms. A key question involves whether optimal treatment of cardiac-induced posttraumatic stress disorder (PTSD) reduces...
Detailed Description
There is a lack of research on the efficacy of psychotherapy and especially EMDR in clinical-induced PTSD. In the light of clinical-induced PTSD having different symptoms than traditional PTSD, this l...
Eligibility Criteria
Inclusion
- Age between 18-70 years
- Men or women
- STEMI (irrespective of troponin, but ST-elevation) or non-STEMI (troponin positive) at the time of the cardiac event, as verified by the cardiologist
- Diagnosis of PTSD caused by the cardiac event
Exclusion
- Psychotic disorder, bipolar disorder, substance abuse as measured with the Mini International Neuropsychiatric Interview (M.I.N.I)
- Acute suicidal ideation as assessed with the M.I.N.I.
- Non-selective beta blockers (e.g., propranolol) during the study period
- Ongoing psychological/psychiatric treatment outside of the trial during the study period
- Visionary problems, e.g. strabismus, which does not allow adequate eye movements
- Insufficient knowledge of the German language
- Expected inability or willingness to follow the study protocol
Key Trial Info
Start Date :
November 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04672551
Start Date
November 21 2020
End Date
November 30 2026
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland